Laura Q.M. Chow
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.2%
- Immunology top 0.5%
- Molecular Biology top 2%
- Cancer Research top 1%
- Co-authors
- S. Gail EckhardtJonathan D. ChengRaanan BergerScott GettingerTanguy Y. SeiwertHossein BorghaeiJared LuncefordNaiyer A. Rizvi
- Topics
- Cancer Immunotherapy and Biomarkers (82 papers)Lung Cancer Treatments and Mutations (60 papers)CAR-T cell therapy research (22 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Laura Q.M. Chow
156 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 9.1k
- Pulmonary and Respiratory Medicine 4.6k
- Immunology 3.0k
- Molecular Biology 2.9k
- Cancer Research 1.6k
Countries citing papers authored by Laura Q.M. Chow
This map shows the geographic impact of Laura Q.M. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Q.M. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Q.M. Chow more than expected).
Fields of papers citing papers by Laura Q.M. Chow
This network shows the impact of papers produced by Laura Q.M. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Q.M. Chow. The network helps show where Laura Q.M. Chow may publish in the future.
Co-authorship network of co-authors of Laura Q.M. Chow
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Q.M. Chow. A scholar is included among the top collaborators of Laura Q.M. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Q.M. Chow. Laura Q.M. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 54 | |
| 4 | 15 | |
| 5 | 10 | |
| 6 | 135 | |
| 7 | 79 | |
| 8 | 3 | |
| 9 | 114 | |
| 10 | 150 | |
| 11 | PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancerbreakdown → | 453 |
| 12 | 183 | |
| 13 | 22 | |
| 14 | 5 | |
| 15 | Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialbreakdown → | 1275 |
| 16 | 8 | |
| 17 | 182 | |
| 18 | 54 | |
| 19 | 24 | |
| 20 | 22 |
About Laura Q.M. Chow
Laura Q.M. Chow is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 159 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (82 papers), Lung Cancer Treatments and Mutations (60 papers) and CAR-T cell therapy research (22 papers). The work is most often cited by research in Oncology (9.1k citations), Otorhinolaryngology (1.2k citations) and Immunology (3.0k citations). Laura Q.M. Chow has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include S. Gail Eckhardt, Jonathan D. Cheng, Raanan Berger, Scott Gettinger, Tanguy Y. Seiwert, Hossein Borghaei, Jared Lunceford, Naiyer A. Rizvi, Scott Antonia and Julie R. Brahmer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.